| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70756-079-11 | 70756-079 | HUMAN PRESCRIPTION DRUG | Bumetanide | Bumetanide | TABLET | ORAL | 20250403 | N/A | ANDA | ANDA219291 | Lifestar Pharma LLC | BUMETANIDE | .5 mg/1 | 100 TABLET in 1 BOTTLE (70756-079-11) |
| 70756-080-11 | 70756-080 | HUMAN PRESCRIPTION DRUG | Bumetanide | Bumetanide | TABLET | ORAL | 20250403 | N/A | ANDA | ANDA219291 | Lifestar Pharma LLC | BUMETANIDE | 1 mg/1 | 100 TABLET in 1 BOTTLE (70756-080-11) |
| 70756-080-51 | 70756-080 | HUMAN PRESCRIPTION DRUG | Bumetanide | Bumetanide | TABLET | ORAL | 20250403 | N/A | ANDA | ANDA219291 | Lifestar Pharma LLC | BUMETANIDE | 1 mg/1 | 500 TABLET in 1 BOTTLE (70756-080-51) |
| 70756-081-11 | 70756-081 | HUMAN PRESCRIPTION DRUG | Bumetanide | Bumetanide | TABLET | ORAL | 20250403 | N/A | ANDA | ANDA219291 | Lifestar Pharma LLC | BUMETANIDE | 2 mg/1 | 100 TABLET in 1 BOTTLE (70756-081-11) |
| 70756-081-51 | 70756-081 | HUMAN PRESCRIPTION DRUG | Bumetanide | Bumetanide | TABLET | ORAL | 20250403 | N/A | ANDA | ANDA219291 | Lifestar Pharma LLC | BUMETANIDE | 2 mg/1 | 500 TABLET in 1 BOTTLE (70756-081-51) |